glp 1 cause kidney issues GLP-1 receptor agonists in patients with chronic disease and either overweight or obesity GLP1 Receptor Agonists vs SGLT2-I

This suggests that under certain experimental conditions, IGF-1 LR3 might exhibit more pronounced anabolic actions, though these were not consistently observed across all the variables measured

Enrique Caballero, MD, highlighted the progress advancing diabetes treatment and management while shedding light on existing gaps in care and advocating for integrating advances in science into the real-world context in which people live

Trials of exenatide in early-stage Parkinson's disease demonstrated enduring motor enhancements (Kong et al

(2022) Furthering the understanding of behavioral aspects of sleep and headaches: another piece of the puzzle